Bal Pharma reports consolidated net loss of Rs 0.88 crore in the March 2017 quarter

Sales rise 21.55% to Rs 65.49 crore

Net Loss of Bal Pharma reported to Rs 0.88 crore in the quarter ended March 2017 as against net loss of Rs 2.62 crore during the previous quarter ended March 2016. Sales rose 21.55% to Rs 65.49 crore in the quarter ended March 2017 as against Rs 53.88 crore during the previous quarter ended March 2016.

For the full year,net profit rose 41.13% to Rs 1.99 crore in the year ended March 2017 as against Rs 1.41 crore during the previous year ended March 2016. Sales rose 17.06% to Rs 232.93 crore in the year ended March 2017 as against Rs 198.99 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales65.4953.88 22 232.93198.99 17 OPM %4.673.40 -6.117.47 - PBDT1.67-0.02 LP 8.859.66 -8 PBT-0.58-2.27 74 2.362.65 -11 NP-0.88-2.62 66 1.991.41 41

Powered by Capital Market - Live News